Automated Author ProfilePirker, Walter
Department of Neurology, Klinik Ottakring, Vienna, Austria
Pirker, Walter
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 2.6 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Participant demographic and clinical characteristics, and urine BMP phospholipid levels. For each participant, sample collection site is provided as: BCN (Barcelona), VIE (Vienna), DND (Dundee), or SSB (San Sebastian). Also provided are age at study participation, age at PD diagnosis (where applicable), sex (M, for male, and F, for female), experimental group (control, iPD –idiopathic PD –, LRRK2 G2019S, LRRK2 R1441G/C, VPS35 D620N, GBA, or other), and PD status (NMC for non-manifesting mutation carriers, or PD). Values for all measured BMP species presented as ng of BMP per mg of creatinine are provided. Additionally, urine creatinine (mg/ml) and non-normalized BMP levels are provided. BQL designates BMP levels that were below quantification level and NM designates values that were not measured for a particular individual.
Authors
- Gomes, Sara ;
- Garrido, Alicia ;
- Tonelli, Francesca ;
- Obiang, Donina ;
- Tolosa, Eduardo ;
- Marti, Maria Jose ;
- Ruiz-Martinez, Javier ;
- Vinagre Aragon, Ana ;
- Hernandez-Eguiazu, Haizea ;
- Croitoru, Ioana ;
- L Marshall, Vicky ;
- Koenig, Theresa ;
- Hotzy, Christoph ;
- Hsieh, Frank ;
- Sakalosh, Marianna ;
- Tengstrand, Elizabeth ;
- Padmanabhan, Shalini ;
- Merchant, Kalpana ;
- Bruecke, Christof ;
- Pirker, Walter ;
- Zimprich, Alexander ;
- Sammler, Esther
Participant demographic and clinical characteristics, and urine BMP phospholipid levels. For each participant, sample collection site is provided as: BCN (Barcelona), VIE (Vienna), DND (Dundee), or SSB (San Sebastian). Also provided are age at study participation, age at PD diagnosis (where applicable), sex (M, for male, and F, for female), experimental group (control, iPD –idiopathic PD –, LRRK2 G2019S, LRRK2 R1441G/C, VPS35 D620N, GBA, or other), and PD status (NMC for non-manifesting mutation carriers, or PD). Values for all measured BMP species presented as ng of BMP per mg of creatinine are provided. Additionally, urine creatinine (mg/ml) and non-normalized BMP levels are provided. BQL designates BMP levels that were below quantification level and NM designates values that were not measured for a particular individual.
Authors
- Gomes, Sara ;
- Garrido, Alicia ;
- Tonelli, Francesca ;
- Obiang, Donina ;
- Tolosa, Eduardo ;
- Marti, Maria Jose ;
- Ruiz-Martinez, Javier ;
- Vinagre Aragon, Ana ;
- Hernandez-Eguiazu, Haizea ;
- Croitoru, Ioana ;
- L Marshall, Vicky ;
- Koenig, Theresa ;
- Hotzy, Christoph ;
- Hsieh, Frank ;
- Sakalosh, Marianna ;
- Tengstrand, Elizabeth ;
- Padmanabhan, Shalini ;
- Merchant, Kalpana ;
- Bruecke, Christof ;
- Pirker, Walter ;
- Zimprich, Alexander ;
- Sammler, Esther